PHarmaceutical tech@2x
  • News

    Most Read

    • NewAmsterdam Pharma raises $196m through Series A funding round
    • FDA approves Pfizer’s Xalkori in ALCL in children, young adults
    • SII expects WHO emergency approval of Covid-19 vaccine soon

    Most Recent

    Drug Development

    NewAmsterdam Pharma raises $196m through Series A funding round

    15 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
    • Biden unveils Covid relief plan to stimulate US economy – leading macroeconomic influencers
    • Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations

    Most Recent

    deal

    Phesi and Sensyne to collaborate on synthetic control arms for clinical trials

    15 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • AzurRx engages CROs Rho and Linical in separate Phase II trials in cystic fibrosis with pancreatic insufficiency
    • Revitope Oncology welcomes CRO and CMO pitches in several months for Phase I trial and drug development
    • GlobalData Epidemiologist Report: Grim milestone reached as global Covid deaths exceed 2 million

    Most Recent

    Clinical Trials

    AzurRx engages CROs Rho and Linical in separate Phase II trials in cystic fibrosis with pancreatic insufficiency

    15 Jan 2021
  • Themes
  • Deals

    Most Read

    • Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
    • Disease-cancelling drugs: Immuneering raises $62m in Series B round
    • Boehringer enters into cancer drug development deal with Enara Bio

    Most Recent

    Drug Development

    NewAmsterdam Pharma raises $196m through Series A funding round

    15 Jan 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kiskun Meridian
    • Baxter BioPharma Solutions
    • E3D Elcam Drug Delivery Devices

    Most Recent

    Drug Development

    Kiskun Meridian

    11 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Cellid signs Covid-19 vaccine research contract with IVI

Cellid signs Covid-19 vaccine research contract with IVI

Cellid and the International Vaccine Institute (IVI) have signed a research service contract to collaborate...

6 January 2021
Samsung Biologics signs Covid-19 therapy manufacturing deal with Lilly

Samsung Biologics signs Covid-19 therapy manufacturing deal with Lilly

17 November 2020
Bridge Biotherapeutics terminates collaboration agreement with Boehringer

Bridge Biotherapeutics terminates collaboration agreement with Boehringer

Bridge Biotherapeutics and Boehringer Ingelheim have mutually agreed to terminate their previously signed collaboration and...

10 November 2020
Humanigen to enter Asia-Pacific market with Covid-19 drug 

Humanigen to enter Asia-Pacific market with Covid-19 drug 

Humanigen has executed a licensing agreement with Telcon RF Pharmaceutical and KPM Tech for development...

4 November 2020
Samsung Biologics’ P4 Super Plant, Songdo

Samsung Biologics’ P4 Super Plant, Songdo

Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth...

20 October 2020
Eisai and Seikagaku partner for osteoarthritis drug in South Korea

Eisai and Seikagaku partner for osteoarthritis drug in South Korea

Japanese pharmaceutical company Eisai has signed a marketing alliance agreement with Seikagaku for SI-613 (diclofenac...

1 October 2020
Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies

Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies

South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at...

22 September 2020
SK bioscience partners with Novavax on Covid-19 vaccine

SK bioscience partners with Novavax on Covid-19 vaccine

South Korea-based SK bioscience has entered into a development and supply agreement for Novavax Covid-19...

14 August 2020
Samsung Biologics to build fourth manufacturing plant

Samsung Biologics to build fourth manufacturing plant

South Korea-based biomedicine maker Samsung Biologics has unveiled plans to build its fourth plant this...

12 August 2020
Daewoong finds niclosamide effective against Covid-19 in animal tests

Daewoong finds niclosamide effective against Covid-19 in animal tests

South Korea-based Daewoong Pharmaceutical has found that its anti-parasitic drug niclosamide had removed SARS-CoV-2, the...

10 June 2020

Latest News

Drug Development

NewAmsterdam Pharma raises $196m through Series A funding round

15 Jan 2021
Regulation

FDA approves Pfizer’s Xalkori in ALCL in children, young adults

15 Jan 2021
Regulation

SII expects WHO emergency approval of Covid-19 vaccine soon

15 Jan 2021
Drug Development

Boehringer enters into cancer drug development deal with Enara Bio

13 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more